Biomerica (BMRA) Research & Development (2010 - 2026)
Biomerica (BMRA) reported Research & Development of $178000.0 for Q1 2026, down 45.4% on a YoY basis from $326000.0 in Q1 2025, and down 7.77% sequentially from $193000.0 in Q4 2025.
Biomerica (BMRA) Research & Development (2010 - 2026) Analysis & Trends
Biomerica (BMRA) has 17 years of Research & Development data on file, last reported at $178000.0 in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 45.4% year-over-year to $178000.0; the trailing twelve-month figure through Feb 2026 stood at $354000.0 (down 69.08% YoY), and the FY2025 full-year result was $1.0 million, down 31.39% from the prior year.
- Research & Development slipped to $178000.0 in Q1 2026, from $193000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $495000.0 in Q2 2022 to a low of -$229000.0 in Q2 2025.
- A 5-year average of $305417.9 and a median of $343000.0 in 2024 frame the typical range for Research & Development.
- Across the five-year window, Research & Development surged 63.93% in 2022 and tumbled 186.42% in 2025, its largest moves.
- Tracing BMRA's Research & Development over 5 years: stood at $462000.0 in 2022, then retreated by 10.82% to $412000.0 in 2023, then sank by 37.62% to $257000.0 in 2024, then slipped by 24.9% to $193000.0 in 2025, then slipped by 7.77% to $178000.0 in 2026.
- Business Quant data shows BMRA's Research & Development at $178000.0 in Q1 2026, $193000.0 in Q4 2025, and $212000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 178,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 178,000.00 |
| Nov 30, 2025 | 193,000.00 |
| Aug 31, 2025 | 212,000.00 |
| May 31, 2025 | -229,000.00 |
| Feb 28, 2025 | 326,000.00 |
| Nov 30, 2024 | 257,000.00 |
| Aug 31, 2024 | 297,000.00 |
| May 31, 2024 | 265,000.00 |
| Feb 29, 2024 | 343,000.00 |
| Nov 30, 2023 | 412,000.00 |
| Aug 31, 2023 | 472,000.00 |
| May 31, 2023 | 369,000.00 |
| Feb 28, 2023 | 392,000.00 |
| Nov 30, 2022 | 462,000.00 |
| Aug 31, 2022 | 361,000.00 |
| May 31, 2022 | 495,000.00 |
| Feb 28, 2022 | 387,104.00 |
| Nov 30, 2021 | 548,000.00 |
| Aug 31, 2021 | 381,544.00 |
| May 31, 2021 | 301,967.00 |